0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letters   |    
Treatment of Catatonia With Zolpidem
Stephanie Peglow, D.O.; Vladimir Prem, M.D.; William McDaniel, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2013;25:E13-E13. doi:10.1176/appi.neuropsych.11120367
View Author and Article Information

Dept. of Psychiatry Eastern Virginia Medical School Norfolk, VA
Veterans Affairs Medical Center Norfolk, VA

Correspondence: Stephanie Peglow, D.O.; peglowsl@evms.edu

Copyright © 2013 American Psychiatric Association

Extract

To the Editor: Zolpidem has been used successfully as a rapid test for patients suspected to be catatonic.1 Lorazepam or electroconvulsive therapy (ECT) are considered the standard of care.2 Zolpidem is well-described as a test for catatonia.3 This case report explores zolpidem as a long-term treatment option when standard therapies are not tolerated or ineffective.

Figures in this Article

First Page Preview

View Large
/>
First page PDF preview

Topics

catatonia ; zolpidem
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

Thomas  P;  Cottencin  O;  Rascle  C  et al:  Catatonia in French psychiatry: implications of the Zolpidem Challenge Test.  Psychiatr Ann 2007; 37:45–54
 
Bush  G;  Fink  M;  Petrides  G  et al:  Catatonia, II: treatment with lorazepam and electroconvulsive therapy.  Acta Psychiatr Scand 1996; 93:137–143
[CrossRef] | [PubMed]
 
Mastain  B;  Vaiva  G;  Guerouaou  D  et al:  [Favorable effect of zolpidem on catatonia].  Rev Neurol (Paris) 1995; 151:52–56
[PubMed]
 
Tu  JB;  Bistow  M:  Neuroleptic malignant syndrome: a psychopharmacogenetic perspective.  J Child Adolesc Psychopharmacol 1996; 6:151–152
[CrossRef] | [PubMed]
 
Ungvari  G;  Kau  L;  Wal-Kwong  T;  Shing  N: The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurol 2001; 251:31–34
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Topic Collections
Psychiatric News
PubMed Articles
Zolpidem-related withdrawal catatonia: a case report. Psychosomatics 2011 Sep-Oct;52(5):475-7.
Treatment of catatonia with zolpidem. J Neuropsychiatry Clin Neurosci 2013;25(3):E13.